Global standard Nanosonics’ trophon technology is described as the global standard of care for ultrasound probe disinfection, signaling a strong opportunity to upsell complementary infection prevention solutions to hospitals and ultrasound service providers worldwide.

Infection prevention As a dedicated infection prevention company with a single focus on high level disinfection, there is potential to cross-sell to healthcare facilities expanding infection control programs, including radiology, anesthesia, and critical care departments.

Expansion readiness With ongoing product and infrastructure enhancements and a growing workforce, Nanosonics appears poised for geographic and vertical expansion, suggesting sales opportunities in new regions and adjacent medical device markets.

Tech stack leverage Utilize the company’s tech stack (Salesforce, continuous delivery, and modern front-end technologies) to drive CRM-led account expansion, targeted marketing campaigns, and streamlined customer success initiatives to improve renewal and upsell cycles.

Financial signals Revenue scale in the mid-range and a history of quarterly and annual earnings discussions indicate a buyer’s environment where value-based propositions around total cost of ownership, device lifecycle, and service contracts could resonate for procurement teams.